Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial

Detalles Bibliográficos
Autores principales: Parra-Lara, Luis Gabriel, Martinez-Arboleda, Juan José, Isaza-Pierotti, Daniel Francisco, Rosso, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779262/
https://www.ncbi.nlm.nih.gov/pubmed/33408017
http://dx.doi.org/10.1016/j.ijantimicag.2020.106172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779262/
https://www.ncbi.nlm.nih.gov/pubmed/33408017
http://dx.doi.org/10.1016/j.ijantimicag.2020.106172

Ejemplares similares